DailyNewsQuiz
Home
About
FAQ
← Home
science
Jan 26
Pig vaccine candidate outperforms leading available treatment in new trials
AI-Generated from
Phys.org - News And Articles On Science And Technology
1.
Who developed the vaccine to tackle Streptococcus suis?
A
The Vaccine Group (TVG)
B
The University of Plymouth
C
Moredun Scientific Limited
D
All of the above
2.
What disease does the vaccine aim to tackle?
A
African Swine Fever
B
Streptococcus suis
C
Foot-and-Mouth Disease
D
Classical Swine Fever
3.
In the challenge trial, how did the vaccine candidate perform compared to a leading commercially available vaccine?
A
It performed worse
B
It performed equally
C
It outperformed
D
It was not tested against a commercially available vaccine
4.
What consortium developed the vaccine candidate?
A
The Vaccine Group (TVG) only
B
The University of Plymouth only
C
Moredun Scientific Limited only
D
An international consortium including TVG, the University of Plymouth, and Moredun Scientific Limited
5.
What type of serotype was the vaccine candidate effective against?
A
Homologous
B
Heterologous
C
Autologous
D
Synteny
Submit Answers